Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease

Current Topics in Microbiology and Immunology

Volumn 275, Issue , 2002, Pages 225-248

  Mornex, J F ^a   Thivolet, F ^a   De las Heras, M ^b   Leroux, C ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P16; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL DISEASE; ANIMAL MODEL; CANCER CLASSIFICATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG TRANSPLANTATION; NONHUMAN; ONCOVIRINAE; PRIORITY JOURNAL; PROTO ONCOGENE; RETROVIRUS; REVIEW; SHEEP DISEASE; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; ANIMALS; BASE SEQUENCE; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; JAAGSIEKTE SHEEP RETROVIRUS; LUNG NEOPLASMS; LUNG TRANSPLANTATION; MALE; MUTATION; PROTO-ONCOGENES; PULMONARY ADENOMATOSIS, OVINE; SHEEP;

ANIMALIA; BETARETROVIRUS; ONCOVIRINAE; OVINE PULMONARY ADENOCARCINOMA VIRUS; OVIS; OVIS ARIES; UNIDENTIFIED RETROVIRUS;

EID: 0036924728     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (62)

1. Barsky SH, Cameron R, Osann KE, Tomita D, Holmes EC (1994) Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 73:1163-70
2. Barsky SH, Grossman DA, Ho J, Holmes EC (1994) The multifocality of bronchioloalveolar lung carcinoma: Evidence and implications of a multiclonal origin. Mod Pathol 7:633-40
3. Bonne C (1939) Morphological resemblance of pulmonary adenomatosis (jaaksiekte) in sheep and certain cases of cancer of the lung in man. Am J Cancer 35:491-501
4. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18:1059-68
5. Breathnach OS, Ishibe N, Williams J, Linnoila RI, Caporaso N, Johnson BE (1999) Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung. Cancer 86:1165-73
6. Breathnach OS, Kwiatkowski DJ, Finkelstein DM, Godleski J, Sugarbaker DJ, Johnson BE, Mentzer S (2001) Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg 121:42-7
7. Caamano J, Ruggeri B, Momiki S, Sickler A, Zhang SY, Klein-Szanto AJ (1991) Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines. Am J Pathol 139:839-45
8. Crawford L (1983) The 53,000-dalton cellular protein and its role in transformation. Int Rev Exp Pathol 25:1-50
9. De las Heras M, Barsky SH, Hasleton P, Wagner M, Larson E, Egan J, Ortin A, Gimenez-Mas JA, Palmarini M, Sharp JM (2000) Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours. Eur Respir J 16:330-2
10. Denissenko MF, Chen JX, Tang MS, Pfeifer GP (1997) Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci USA 94:3893-8
11. Denissenko MF, Pao A, Tang M, Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274:430-2
12. Etienne B, Bertocchi M, Gamondes JP, Wiesendanger T, Brune J, Mornex JF (1997) Successful double-lung transplantation for bronchioalveolar carcinoma. Chest 112:1423-4
13. Falk RT, Pickle LW, Fontham ET, Greenberg SD, Jacobs HL, Correa P, Fraumeni JF Jr (1992) Epidemiology of bronchioloalveolar carcinoma. Cancer Epidemiol Biomarkers Prev 1:339-44
14. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-67
15. Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD (1997) FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 57:2256-67
16. Fong KM, Sekido Y, Minna JD (1999) Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg 118:1136-52
17. Galy P, Marcq M (1973) Le carcinome bronchiolo-alvéolaire. Rev Fr Mal Respir 1:665-682
18. Garver RI Jr, Zorn GL, Wu X, McGiffin DC, Young KR Jr, Pinkard NB (1999) Recurrence of bronchioloalveolar carcinoma in transplanted lungs. N Engl J Med 340:1071-4
19. Gazzeri S, Brambilla E, Caron de Fromentel C, Gouyer V, Moro D, Perron P, Berger F, Brambilla C (1994) p53 genetic abnormalities and myc activation in human lung carcinoma. Int J Cancer 58:24-32
20. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-78
21. Hainaut P, Pfeifer GP (2001) Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 22:367-74
22. Hernandez-Boussard TM, Hainaut P (1998) A specific spectrum of p53 mutations in lung cancer from smokers: Review of mutations compiled in the IARC p53 database. Environ Health Perspect 106:385-91
23. Hod I, Herz A, Zimber A (1977) Pulmonary carcinoma (Jaagsiekte) of sheep. Ultrastructural study of early and advanced tumor lesions. Am J Pathol 86:545-58
24. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
25. Keohavong P, DeMichele MA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM (1996) Detection of K-ras mutations in lung carcinomas: Relationship to prognosis. Clin Cancer Res 2:411-8
26. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159-70
27. Kishimoto Y, Murakami Y, Shiraishi M, Hayashi K, Sekiya T (1992) Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res 52:4799-804
28. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323-31
29. Liu YY, Chen YM, Huang MH, Perng RP (2000) Prognosis and recurrent patterns in bronchioloalveolar carcinoma. Chest 118:940-7
30. Marchetti A, Buttitta F, Pellegrini S, Chella A, Bertacca G, Filardo A, Tognoni V, Ferreli F, Signorini E, Angeletti CA, Bevilacqua G (1996) Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype. J Pathol 179:254-9
31. Marchetti A, Pellegrini S, Bertacca G, Buttitta F, Gaeta P, Carnicelli V, Nardini V, Griseri P, Chella A, Angeletti CA, Bevilacqua G (1998) FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations. J Pathol 184:240-6
32. Marchevsky AM (1990) Malignant epithelial tumors of the lung. In: Marchevsky AM (ed. eds) Surgical Pathology of Lung Neoplasms. Marcel Dekker, New York, pp 77-228
33. Marcq M, Galy P (1973) Bronchioloalveolar carcinoma. Clinicopathologic relationships, natural history, and prognosis in 29 cases. Am Rev Respir Dis 107:621-9
34. Mills NE, Fishman CL, Rom WN, Dubin N, Jacobson DR (1995) Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res 55:1444-7
35. Morabia A, Wynder EL (1992) Relation of bronchioloalveolar carcinoma to tobacco. BMJ 304:541-3
36. Nobel TA, Perk K (1978) Bronchiolo-alveolar cell carcinoma. Animal model: Pulmonary adenomatosis of sheep, pulmonary carcinoma of sheep, pulmonary carcinoma of sheep (Jaagsiekte). Am J Pathol 90:783-6
37. Nuorva K, Soini Y, Kamel D, Pollanen R, Bloigu R, Vahakangas K, Paakko P (1995) p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int J Cancer 64:424-9
38. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T et al. (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and rena 1 carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-97
39. Okubo K, Mark EJ, Flieder D, Wain JC, Wright CD, Moncure AC, Grillo HC, Mathisen DJ (1999) Bronchoalveolar carcinoma: Clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg 118:702-9
40. OMS (1981) Types Histologiques des Tumeurs du Poumon. Genève, Organisation mondiale de la santé
41. Pace HC, Garrison PN, Robinson AK, Barnes LD, Draganescu A, Rosler A, Blackburn GM, Siprashvili Z, Croce CM, Huebner K, Brenner C (1998) Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. Proc Natl Acad Sci USA 95:5484-9
42. Palmarini M, Hallwirth C, York D, Murgia C, de Oliveira T, Spencer T et al. (2000) Molecular cloning and functional analysis of three type D endogenous retroviruses of sheep reveal a different cell tropism from that of the highly related exogenous jaagsiekte sheep retrovirus. J Virol 74(17):8065-76
43. Palmarini M, Fan H (2001) Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer. J Natl Cancer Inst 93:1603-14
44. Paloyan EB, Swinnen LJ, Montoya A, Lonchyna V, Sullivan HJ, Garrity E (2000) Lung transplantation for advanced bronchioloalveolar carcinoma confined to the lungs. Transplantation 69:2446-8
45. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN (1994) K-ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54:1556-60
46. Regnard JF, Santelmo N, Romdhani N, Gharbi N, Bourcereau J, Dulmet E, Levasseur P (1998) Bronchioloalveolar lung carcinoma: Results of surgical treatment and prognostic factors. Chest 114:45-50
47. Rusch VW, Reuter VE, Kris MG, Kurie J, Miller WH, JR., Nanus DM, Albino AP, Dmitrovsky E (1992) Ras oncogene point mutation: An infrequent event in bronchioloalveolar cancer. J Thorac Cardiovasc Surg 104:1465-9
48. Saleh HA, Haapaniemi J, Khatib G, Sakr W (1998) Bronchioloalveolar carcinoma: Diagnostic pitfalls and immunocytochemical contribution. Diagn Cytopathol 18: 301-6
49. Siegfried JM, Gillespie AT, Mera R, Casey TJ, Keohavong P, Testa JR, Hunt JD (1997) Prognostic value of specific KRAS mutations in lung adenocarcinomas. Cancer Epidemiol Biomarkers Prev 6:841-7
50. Silini EM, Bosi F, Pellegata NS, Volpato G, Romano A, Nazari S, Tinelli C, Ranzani GN, Solcia E, Fiocca R (1994) K-ras gene mutations: An unfavorable prognostic marker in stage I lung adenocarcinoma. Virchows Arch 424:367-73
51. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K (1997) Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 94:13771-6
52. Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, van Zandwijk N, Mooi WJ et al. (1990) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323:561-5
53. Sorensen JB, Hirsch FR, Gazdar A, Olsen JE (1993) Interobserver variability in histopathologic subtyping and grading of pulmonary adenocarcinoma. Cancer 71: 2971-6
54. Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, Minoletti F, Pilotti S, Ratcliffe C, Veronese ML, Goldstraw P, Hoebner K, Croce CM, Pierotti MA (1997) Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res 57:5207-12
55. Thomas R, Kaplan L, Reich N, Lane DP, Levine AJ (1983) Characterization of human p53 antigens employing primate specific monoclonal antibodies. Virology 131:502-17
56. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E (1999) Histological typing of lung and pleural tumours, Springer Travis WD, Travis LB, Devesa SS (1995) Lung Cancer. Cancer 75:191-202
57. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-32
58. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network Nature 408:307-10
59. Wang X, Rao MS, Yeldandi AM (1995) Immunohistochemical analysis of p53 mutations in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma. Mod Pathol 8:919-23
60. Weintraub SJ (1996) Inactivation of tumor suppressor proteins in lung cancer. Am J Respir Cell Mol Biol 15:150-5
61. Yousem SA, Finkelstein SD, Swalsky PA, Bakker A, Ohori NP (2001) Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol 32:1039-42
62. Zochbauer-Muller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD (2001) 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 61:3581-5